TPIsoftware's AI-Powered SysTalk.Chat to Elevate Chang Gung Me... - 13 January 2023 14:11

TAIPEI, Jan. 13, 2023 /PRNewswire-AsiaNet/ -- Taking the trophy as the one of the best products in Taiwan at Taiwan Excellence Awards 2023, TPIsoftware's SysTalk.Chat(https://www.tpisoftware.com/en/products/systalk-chat), the conversational AI chatbot, has reached new heights in driving smart...

  DEBIOPHARM APPLIES EXTENDED-RELEASE FORMULATION EXPERTISE TO R... - 12 January 2023 11:00

LAUSANNE, Switzerland, January 12, 2023, /PRNewswire-AsiaNet/-- -  Acromegaly and gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare diseases that require life-long chronic treatment. Monthly somatostatin analog (SSA) injections are the standard of care as first-line medical treatment. -  Debi...

  Mars Petcare and the Broad Institute create open-access databa... - 12 January 2023 04:24

NEW YORK, Jan. 11, 2023 /PRNewswire-AsiaNet/-- - The genome database will power ongoing scientific efforts worldwide and help advance individualized pet health care - Insights from this partnership will feed into the MARS PETCARE BIOBANK(TM), a longitudinal study to understand pet health and ...

  MedAlliance SELUTION SLR is the first DEB to receive coronary ... - 11 January 2023 11:00

GENEVA, Jan. 11, 2023 /PRNewswire-Asianet/ SELUTION SLR(TM), MedAlliance's novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of coronary de novo lesions. This com...

  Ajinomoto and Exelixis Enter Into a License Agreement to Disco... - 11 January 2023 00:05

TOKYO, Jan. 10, 2023 /PRNewswire-AsiaNet/ -- Ajinomoto Co., Inc. ("Ajinomoto Co.") today announced a license agreement with Exelixis, Inc. ("Exelixis") to incorporate AJICAP(R), Ajinomoto Co.'s proprietary site-specific bioconjugation and linker technologies, in the development of certain of...

  Renexxion Announces Opening of Investigational New Drug (IND) ... - 11 January 2023 00:00

ROSCREA, Ireland, Jan.10, 2023 /PRNewswire-AsiaNet/-- Renexxion Ireland Limited (Renexxion), a private biopharmaceutical company committed to delivering innovative drugs to patients with high unmet need in gastrointestinal ("GI") disorders, is pleased to announce opening of the Investigational New Dr...

  Sai Life Sciences inks strategic agreement to set up Schröding... - 10 January 2023 20:50

HYDERABAD, India, Jan. 10, 2023 /PRNewswire-AsiaNet/ -- Sai Life Sciences, one of India's fastest growing global Contract Research, Development & Manufacturing Organisations [ https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=schrodinger-offshore-research-lab ] (CRO-CDMO), today an...

  CES 2023: OMRON Healthcare to Unveil New Efforts to Realize Vi... - 06 January 2023 17:00

KYOTO, Japan, Jan. 6, 2023 /Kyodo JBN-Asianet/ -- - "Viso," New UK Remote Patient Monitoring Service, to Be Launching in Early 2023 - OMRON Healthcare Co., Ltd. (hereinafter the Company) is unveiling a new UK remote patient-monitoring service to realize its "Going for Zero" vision to eliminat...

  B dot Medical to Install Its First Practical Ultra-compact Pro... - 05 January 2023 18:00

TOKYO, Jan. 5, 2023 /Kyodo JBN-Asianet/ -- - Memorandum of Understanding Signed with Edogawa Hospital - B dot Medical Inc. has signed a memorandum of understanding with Edogawa Hospital in Japan for the installation of the company's first practical ultra-compact proton therapy system, w...

  DiscGenics to Present at 41st Annual J.P. Morgan Healthcare Co... - 05 January 2023 11:00

SALT LAKE CITY, Jan. 5, 2023 /PRNewswire-AsiaNet/ -- DiscGenics, Inc. ( https://c212.net/c/link/?t=0&l=en&o=3748183-1&h=827169717&u=https%3A%2F%2Fwww.discgenics.com%2F&a=DiscGenics ), a privately held, clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies t...